Zhejiang DiAn Diagnostics Co

SHE:300244 China Diagnostics & Research
Market Cap
$1.67 Billion
CN¥12.26 Billion CNY
Market Cap Rank
#6801 Global
#1085 in China
Share Price
CN¥19.61
Change (1 day)
-2.15%
52-Week Range
CN¥12.63 - CN¥29.50
All Time High
CN¥46.17
About

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more

Zhejiang DiAn Diagnostics Co - Asset Resilience Ratio

Latest as of September 2025: 3.45%

Zhejiang DiAn Diagnostics Co (300244) has an Asset Resilience Ratio of 3.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥509.56 Million
Cash + Short-term Investments
Total Assets
CN¥14.77 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Zhejiang DiAn Diagnostics Co's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang DiAn Diagnostics Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥509.56 Million 3.45%
Total Liquid Assets CN¥509.56 Million 3.45%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang DiAn Diagnostics Co maintains only 3.45% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang DiAn Diagnostics Co Industry Peers by Asset Resilience Ratio

Compare Zhejiang DiAn Diagnostics Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Zhejiang DiAn Diagnostics Co (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang DiAn Diagnostics Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.44% CN¥384.59 Million CN¥15.79 Billion +0.10pp
2023-12-31 2.33% CN¥418.30 Million CN¥17.94 Billion +0.19pp
2022-12-31 2.14% CN¥450.09 Million CN¥21.06 Billion -0.60pp
2021-12-31 2.74% CN¥427.22 Million CN¥15.59 Billion +0.24pp
2020-12-31 2.50% CN¥310.26 Million CN¥12.40 Billion -0.23pp
2019-12-31 2.73% CN¥293.24 Million CN¥10.75 Billion --
pp = percentage points